2015
DOI: 10.1016/j.bbi.2015.05.007
|View full text |Cite
|
Sign up to set email alerts
|

The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
41
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 32 publications
(42 citation statements)
references
References 56 publications
1
41
0
Order By: Relevance
“…TLR4 was not detectable in sham controls ( not shown ; see Refs 33,58). Rad, stratum radiatum ( d,e ).…”
Section: Figurementioning
confidence: 87%
See 1 more Smart Citation
“…TLR4 was not detectable in sham controls ( not shown ; see Refs 33,58). Rad, stratum radiatum ( d,e ).…”
Section: Figurementioning
confidence: 87%
“…Their convergent IL-1R1 and TLR4 signaling activation in neurons has been previously reported to modulate neuronal functions, for example by inducing post-translational changes in glutamate or GABAA receptor-gated channels [43, 44, 57]. Notably, TLR4 expression was undetectable by immunohistochemistry in sham rats [33, 58]. However, basal level of TLR4 expression were measured using RTqPCR [59, 60].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, we may speculate about the existence of a reinforcing feedback loop between NF-kB pathway and the immunoproteasome system, which may play a crucial role in perpetuating the pro-epileptogenic inflammatory response in epilepsy. Interestingly, Mishto et al [18] provide additional experimental evidence of the regulation of β5i subunit by TLR4 signaling in epileptogenic tissue.…”
Section: Discussionmentioning
confidence: 99%
“…An example of the possible use of inhibition of the immunoproteasome as therapeutic strategy in epilepsy is represented by the study of Mishto and colleagues [18] in which specific inhibition of the β5i subunit by ONX-0914 [64] resulted in prevention, or significant delay, of 4-aminopyridine-induced seizure-like events in acute rat hippocampal/entorhinal cortex slices, particularly in slices of epileptic rats. Clinically approved proteasome inhibitors targeting the catalytic activity of both the constitutive proteasome and the immunoproteasome have been already used in hematological malignancies [6567].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation